Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”.

HOME
>
論文・技術情報
>
Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”.

アブストラクト
ジャーナル名	JMIRx med
Pubmed追加日	2024/5/13
投稿者	Makunts, Tigran; Joulfayan, Haroutyun; Abagyan, Ruben
組織名	Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California;San Diego, La Jolla, CA, United States.;University of California San Diego, La Jolla, CA, United States.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/38738852/